Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C21H19ClN4O |
| Molecular Weight | 378.855 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(O)CN1N=C(C2=C1N=NC(C3=CC=CC=C3)=C2Cl)C4=CC=CC=C4
InChI
InChIKey=TVNSCKMVODVWRS-UHFFFAOYSA-N
InChI=1S/C21H19ClN4O/c1-21(2,27)13-26-20-16(18(25-26)14-9-5-3-6-10-14)17(22)19(23-24-20)15-11-7-4-8-12-15/h3-12,27H,13H2,1-2H3
| Molecular Formula | C21H19ClN4O |
| Molecular Weight | 378.855 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 05:36:28 GMT 2025
by
admin
on
Wed Apr 02 05:36:28 GMT 2025
|
| Record UNII |
AW4QOD73S3
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
711419
Created by
admin on Wed Apr 02 05:36:28 GMT 2025 , Edited by admin on Wed Apr 02 05:36:28 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
AW4QOD73S3
Created by
admin on Wed Apr 02 05:36:28 GMT 2025 , Edited by admin on Wed Apr 02 05:36:28 GMT 2025
|
PRIMARY | |||
|
66576257
Created by
admin on Wed Apr 02 05:36:28 GMT 2025 , Edited by admin on Wed Apr 02 05:36:28 GMT 2025
|
PRIMARY | |||
|
1404506-35-9
Created by
admin on Wed Apr 02 05:36:28 GMT 2025 , Edited by admin on Wed Apr 02 05:36:28 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET->LIGAND |
|
||
|
TARGET -> ACTIVATOR |
BF844 treatment induced about 6% of total CLRN1N48K to be transported to the plasma membrane
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|
